Equities

Elbit Medical Technologies Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
EMTC-M:TLV

Elbit Medical Technologies Ltd

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (ILa)22.20
  • Today's Change-1.80 / -7.50%
  • Shares traded80.00k
  • 1 Year change-14.62%
  • Beta0.9434
Data delayed at least 20 minutes, as of Feb 17 2026 15:24 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Elbit Medical Technologies Ltd is an Israel-based company engaged in the healthcare sector. It is a holding Company which was established in order to gather all of Elbit groups' bio medical and medical devices investments under one entity. Elbit Medical Technologies Ltd's medical division includes investment in InSightec Ltd that is engaged in the development, production and marketing of magnetic resonance imaging guided ultrasound equipment as well as investment in Gamida Cell Ltd that is engaged in the development of stem cell therapeutics based on its proprietary technologies for stem cell expansion as well as future regenerative cell-based medicines including heart tissue repair.

  • Revenue in ILS (TTM)2.08m
  • Net income in ILS851.07k
  • Incorporated1992
  • Employees232.00
  • Location
    Elbit Medical Technologies LtdMetsada St 9BNEI BRAK 5120109IsraelISR
  • Phone+972 36086000
  • Fax+972 36086050
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Human Xtensions Ltd105.00k-9.37m5.43m3.00--1.65--51.73-0.3489-0.34890.0040.12280.00841.410.09735,000.00-75.17-44.43-97.96-49.43-2,663.8143.40-8,927.62-577.623.97--0.00---86.57-44.1037.30---64.33--
Nextgen Biomed Ltd0.00-9.55m7.04m187.00---------0.9109-0.91090.00-0.75840.00-------944.77-65.21---74.65-----------40.21--------65.53------
Erika Carmel Tech Ltd39.63m-11.45m21.25m----1.59--0.5362-0.11-0.110.38050.12861.040.90926.87---30.04-18.36-53.79-26.3761.0386.48-28.90-18.900.6648-12.590.156--27.03-5.6750.73---33.83--
Elbit Medical Technologies Ltd2.08m851.07k21.77m232.0025.600.8905--10.480.00940.00940.02290.26950.0847--36.43--3.4754.063.5455.4012.61--40.9561.64----0.00--282.18-39.79104.65------
Bio View Ltd17.88m-9.67m23.63m33.00--1.06--1.32-0.0724-0.07240.13380.16020.50471.233.73541,848.50-27.300.4609-37.170.612746.3659.56-54.090.60941.58-10.310.0854---26.21-6.44-921.93---29.98--
BioLight Life Sciences Ltd21.00k-14.05m29.83m4.00--0.7906--1,420.47-2.95-2.950.00444.170.0006--0.027---47.82-21.57-52.72-22.97-----86,261.91-13,619.35---2.740.0051--85.59-5.9172.55---0.6994--
Allmed Solutions Ltd0.00-12.37m37.51m22.00--1.12-----0.1328-0.13280.000.33620.00----0.00-28.18-9.16-31.98-10.12--55.39---170.44---25.090.0139-------715.47--8.08--
Nissan Medical Industries Ltd640.72m1.00k89.90m406.00--0.44993.170.1403-0.0088-0.008872.7322.000.92964.127.141,578,126.00-0.03613.80-0.07927.1111.3618.52-0.03893.900.49170.89170.3751---9.521.8739.95-12.83-9.20--
Pulsenmore Ltd9.31m-44.00m108.34m63.00--1.41--11.64-6.86-6.861.4511.810.0660.24722.23147,777.80-31.20-23.53-34.52-25.3237.36---472.58-555.166.44-32.440.2476--56.12--37.28--23.66--
Data as of Feb 17 2026. Currency figures normalised to Elbit Medical Technologies Ltd's reporting currency: Israeli Shekel ILS

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Ayalon Mutual Funds Ltd.as of 27 Nov 20250.000.00%
Data from 30 Nov 2025 - 30 Nov 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.